Purchase Order 75N93019P00893

<p>This federal contract award ID 75N93020P00958 was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the prime contractor OZ Biosciences USA, Inc. The $18,307.40 firm fixed price purchase order is for the delivery of VIROMAG TRANSFECTION REAGENT. The contract has no set-aside designation and has an ultimate completion date of July 23, 2021.</p>

<p>The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $12,058.80 firm fixed price purchase order contract to OZ Biosciences USA, Inc. for the provision of transfection reagents. The contract has a total small business set-aside designation and was awarded on August 1, 2017, with an ultimate completion date of August 31, 2017. This appears to be a standalone contract, not associated with a larger contract vehicle.</p>

<p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to OZ Biosciences USA, Inc. on May 4, 2016. The contract, valued at $7,034.30, is for the product VIROMAG and does not have a set-aside designation. The place of performance is San Diego, CA 92117. OZ Biosciences USA, Inc. is a for-profit organization located in the United States. The contract has a completion date of May 10, 2016.</p>

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to OZ Biosciences USA, Inc. The contract is for the supply of a VIROMAG 1000UL, catalog number VM41000, at a ceiling value of $9,943.00. The contract does not have a set-aside designation and was awarded on September 9, 2015, with a completion date of October 9, 2015. OZ Biosciences USA, Inc. is the prime contractor...

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $11,130 firm fixed price purchase order to Mission Bio, Inc. for biological supplies and reagent kits. The place of performance will be Mission Bio's location in South San Francisco, California. The period of performance is from August 28, 2023 through October 15, 2023. As the National Institute of Allergy and Infectious Diseases conducts research on...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation valued at $49,500 on August 15, 2017, with completion by September 14, 2017. Performance occurs in Carlsbad, California. The order is firm fixed price with no small business set-aside. The specific requirements and line items are not detailed in the source documentation.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation valued at $50,000 on June 13, 2017, with completion by June 23, 2017. The order is firm fixed price with no set-aside applied. Work is performed in Carlsbad, California. The procurement covers laboratory instrumentation, reagents, or consumables consistent with Life Technologies' core product line in genetic analysis and molecular biology systems; the specific item description...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $74,878 purchase order to Pacific Biosciences of California, Inc. for biological reagents and buffers to support the Vaccine Research Center's work. As a prime contractor, Pacific Biosciences will provide the requested products for use at its West Menlo Park, California division. The firm fixed price order runs from June 23, 2023 through July 31, 2023 to...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $46,200.00 on June 25, 2019, with completion scheduled for June 27, 2020. The order covers biologicals for delivery to Carlsbad, California. The underlying solicitation was posted June 3, 2019 with a due date of June 17, 2019. Pricing is firm fixed price.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Invivogen for $22,176.00 on July 9, 2020. Work is performed in San Diego, California. The order covers VACCIGRADE - 1MG VAC-2395-1 as a firm fixed-price purchase. The order completion date is August 7, 2020.</p>